Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aduro biotech
alzheimer's disease
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
drug prices
eli lilly
indiana blog main
indiana top stories
johnson & johnson
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
What
bio
2
×
companies
drug
price
2
×
roundup
alzheimer’s
approval
biogen’s
biopharmaceutical
convo
different
earlier
fail
failures
gene
increases
latest
littered
nash
new
news
pharmaceutical
plan
prescription
prices
raise
remains
road
start
strategy
talk
therapies
typically
year
Language
Current search:
price
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
